Your browser doesn't support javascript.
loading
A universal design of restructured dimer antigens: Development of a superior vaccine against the paramyxovirus in transgenic rice.
Ma, Fanshu; Xu, Qianru; Wang, Aiping; Yang, Daichang; Li, Qingmei; Guo, Junqing; Zhang, Longxian; Ou, Jiquan; Li, Rui; Yin, Heng; Li, Kunpeng; Wang, Li; Wang, Yanan; Zhao, Xiangyue; Niu, Xiangxiang; Zhang, Shenli; Li, Xueyang; Chai, Shujun; Zhang, Erqin; Rao, Zihe; Zhang, Gaiping.
Afiliação
  • Ma F; International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, China.
  • Xu Q; School of Advanced Agriculture Sciences, Peking University, Beijing 100871, China.
  • Wang A; Longhu Laboratory of Advanced Immunology, Zhengzhou 450046, China.
  • Yang D; College of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.
  • Li Q; Chinese Academy of Sciences Key Laboratory of Nano-Bio Interface, Division of Nanobiomedicine, Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, Suzhou 215123, China.
  • Guo J; School of Basic Medical Sciences, Henan University, Kaifeng 475004, China.
  • Zhang L; College of Life Sciences, Zhengzhou University, Zhengzhou 450001, China.
  • Ou J; State Key Laboratory of Hybrid Rice, College of Life Sciences, Wuhan University, Wuhan 430074, China.
  • Li R; Key Laboratory of Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002, China.
  • Yin H; Key Laboratory of Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002, China.
  • Li K; International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, China.
  • Wang L; Longhu Laboratory of Advanced Immunology, Zhengzhou 450046, China.
  • Wang Y; Wuhan Healthgen Biotechnology Corp., Wuhan 430074, China.
  • Zhao X; Key Laboratory of Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002, China.
  • Niu X; Wuhan Healthgen Biotechnology Corp., Wuhan 430074, China.
  • Zhang S; Wuhan Healthgen Biotechnology Corp., Wuhan 430074, China.
  • Li X; Key Laboratory of Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002, China.
  • Chai S; Key Laboratory of Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002, China.
  • Zhang E; Key Laboratory of Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002, China.
  • Rao Z; International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, China.
  • Zhang G; International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, China.
Proc Natl Acad Sci U S A ; 121(4): e2305745121, 2024 Jan 23.
Article em En | MEDLINE | ID: mdl-38236731
ABSTRACT
The development of vaccines, which induce effective immune responses while ensuring safety and affordability, remains a substantial challenge. In this study, we proposed a vaccine model of a restructured "head-to-tail" dimer to efficiently stimulate B cell response. We also demonstrate the feasibility of using this model to develop a paramyxovirus vaccine through a low-cost rice endosperm expression system. Crystal structure and small-angle X-ray scattering data showed that the restructured hemagglutinin-neuraminidase (HN) formed tetramers with fully exposed quadruple receptor binding domains and neutralizing epitopes. In comparison with the original HN antigen and three traditional commercial whole virus vaccines, the restructured HN facilitated critical epitope exposure and initiated a faster and more potent immune response. Two-dose immunization with 0.5 µg of the restructured antigen (equivalent to one-127th of a rice grain) and one-dose with 5 µg completely protected chickens against a lethal challenge of the virus. These results demonstrate that the restructured HN from transgenic rice seeds is safe, effective, low-dose useful, and inexpensive. We provide a plant platform and a simple restructured model for highly effective vaccine development.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Oryza / Vacinas Virais / Paramyxovirinae Limite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Oryza / Vacinas Virais / Paramyxovirinae Limite: Animals Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2024 Tipo de documento: Article